Similar content being viewed by others Introduction The glucagon-like peptide-1 receptor (GLP-1R), is a prototypical class B GPCR involved in the regulation of glucose homeostasis, food intake, inflammation and hypertension [1, 2]
The 12mg group may have had different baseline compositions, or the additional weight loss at 12mg may have included a slightly higher proportion of lean tissue
These medicines work by mimicking the action of a naturally occurring hormone called GLP-1, which is released from the intestine in response to food intake
Increased Energy Expenditure: Activation of the glucagon receptor encourages the body to break down stored fat and increases the metabolic rate, further supporting weight loss
Triple GLP-1/GIP/Glucagon Receptor Agonist Retatrutide is a tri-agonist research peptide studied for its effects on fat metabolism, appetite regulation, and energy expenditure
Type 2 diabetes in adults: management Initial medicines (NG28)
